DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $721,723 | -8.1% | 2,909 | -11.1% | 0.06% | -4.5% |
| Q2 2023 | $785,520 | -86.1% | 3,273 | -85.4% | 0.07% | -86.7% |
| Q1 2023 | $5,641,159 | -0.5% | 22,382 | +4.7% | 0.50% | -3.3% |
| Q4 2022 | $5,672,032 | -8.6% | 21,370 | -11.1% | 0.52% | -16.0% |
| Q3 2022 | $6,209,000 | +104.5% | 24,040 | +100.8% | 0.62% | +119.9% |
| Q2 2022 | $3,036,000 | -60.8% | 11,973 | -54.7% | 0.28% | -57.5% |
| Q1 2022 | $7,746,000 | +2.9% | 26,408 | +15.5% | 0.66% | +7.8% |
| Q4 2021 | $7,525,000 | +27.4% | 22,872 | +17.9% | 0.61% | +13.9% |
| Q3 2021 | $5,907,000 | -0.5% | 19,403 | -12.3% | 0.54% | -10.0% |
| Q2 2021 | $5,934,000 | +16.6% | 22,112 | -2.2% | 0.60% | +11.6% |
| Q1 2021 | $5,088,000 | -13.5% | 22,606 | -14.6% | 0.54% | -10.2% |
| Q4 2020 | $5,880,000 | +5.5% | 26,467 | +2.3% | 0.60% | -4.8% |
| Q3 2020 | $5,572,000 | -1.5% | 25,877 | -19.1% | 0.63% | -5.7% |
| Q2 2020 | $5,657,000 | +24.9% | 31,990 | -2.2% | 0.66% | +6.1% |
| Q1 2020 | $4,529,000 | -24.1% | 32,725 | -15.8% | 0.63% | -7.7% |
| Q4 2019 | $5,964,000 | +16.0% | 38,858 | +9.2% | 0.68% | +2.1% |
| Q3 2019 | $5,141,000 | -1.0% | 35,596 | -2.1% | 0.66% | -5.1% |
| Q2 2019 | $5,193,000 | +4.4% | 36,344 | -3.6% | 0.70% | +1.2% |
| Q1 2019 | $4,974,000 | +10.2% | 37,686 | -13.9% | 0.69% | +0.1% |
| Q4 2018 | $4,512,000 | +53.2% | 43,756 | +61.4% | 0.69% | +71.7% |
| Q3 2018 | $2,946,000 | +5.8% | 27,118 | -3.9% | 0.40% | +2.0% |
| Q2 2018 | $2,784,000 | -0.4% | 28,219 | -1.1% | 0.40% | -1.5% |
| Q1 2018 | $2,794,000 | +24.0% | 28,547 | +17.5% | 0.40% | +25.7% |
| Q4 2017 | $2,254,000 | +2.1% | 24,286 | -5.6% | 0.32% | -0.6% |
| Q3 2017 | $2,207,000 | -20.5% | 25,734 | -21.8% | 0.32% | -21.9% |
| Q2 2017 | $2,775,000 | -1.0% | 32,887 | +0.4% | 0.41% | -4.4% |
| Q1 2017 | $2,802,000 | -16.8% | 32,764 | -24.3% | 0.43% | -21.0% |
| Q4 2016 | $3,367,000 | -4.6% | 43,256 | -4.0% | 0.54% | -4.7% |
| Q3 2016 | $3,531,000 | -24.3% | 45,054 | -2.5% | 0.57% | -26.9% |
| Q2 2016 | $4,667,000 | – | 46,210 | – | 0.78% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |